Clinical trial
A Randomized, Controlled, Open-label, Parallel Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
NCT03547336 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Open-label, Parallel Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration
- Lead sponsor
- Vantive Health LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 29, 2018
- Completion date
- January 4, 2020
- Enrollment
- 212 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease